
<!DOCTYPE article
  PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.4 20241031//EN" "JATS-archivearticle1-4-mathml3.dtd">
<article xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Mil Med</journal-id><journal-id journal-id-type="iso-abbrev">Mil Med</journal-id><journal-id journal-id-type="pmc-domain-id">3647</journal-id><journal-id journal-id-type="pmc-domain">milmed</journal-id><journal-id journal-id-type="nlm-id">2984771R</journal-id><journal-id journal-id-type="publisher-id">milmed</journal-id><journal-title-group><journal-title>Military Medicine</journal-title></journal-title-group><issn pub-type="ppub">0026-4075</issn><issn pub-type="epub">1930-613X</issn><?publisher_abbrev oup?><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11737321</article-id><article-id pub-id-type="pmcid-ver">PMC11737321.1</article-id><article-id pub-id-type="pmcaid">11737321</article-id><article-id pub-id-type="pmcaiid">11737321</article-id><article-id pub-id-type="pmid">39028222</article-id><article-id pub-id-type="doi">10.1093/milmed/usae353</article-id><article-id pub-id-type="publisher-id">usae353</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review Articles</subject></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/MED00010</subject></subj-group></article-categories><title-group><article-title>Evaluating the Phenotypic Patterns of Post-Traumatic Headache: A Systematic Review of Military Personnel</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0105-1064</contrib-id><name name-style="western"><surname>Lyons</surname><given-names initials="HS">Hannah S</given-names></name><degrees>MBChB</degrees><aff>
<institution content-type="department">Translational Brain Science, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham</institution>, Birmingham B15 2TT, <country country="GB">UK</country></aff><aff>
<institution content-type="department">Department of Neurology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust</institution>, Birmingham B15 2WB, <country country="GB">UK</country></aff><xref rid="FT0001" ref-type="author-notes"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0384-7296</contrib-id><name name-style="western"><surname>Sassani</surname><given-names initials="M">Matilde</given-names></name><degrees>PhD</degrees><aff>
<institution content-type="department">Translational Brain Science, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham</institution>, Birmingham B15 2TT, <country country="GB">UK</country></aff><aff>
<institution content-type="department">Department of Neurology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust</institution>, Birmingham B15 2WB, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7772-2157</contrib-id><name name-style="western"><surname>Thaller</surname><given-names initials="M">Mark</given-names></name><degrees>PhD</degrees><aff>
<institution content-type="department">Translational Brain Science, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham</institution>, Birmingham B15 2TT, <country country="GB">UK</country></aff><aff>
<institution content-type="department">Department of Neurology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust</institution>, Birmingham B15 2WB, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8905-5734</contrib-id><name name-style="western"><surname>Yiangou</surname><given-names initials="A">Andreas</given-names></name><degrees>MBBS</degrees><aff>
<institution content-type="department">Translational Brain Science, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham</institution>, Birmingham B15 2TT, <country country="GB">UK</country></aff><aff>
<institution content-type="department">Department of Neurology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust</institution>, Birmingham B15 2WB, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5560-802X</contrib-id><name name-style="western"><surname>Grech</surname><given-names initials="O">Olivia</given-names></name><degrees>PhD</degrees><aff>
<institution content-type="department">Translational Brain Science, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham</institution>, Birmingham B15 2TT, <country country="GB">UK</country></aff><aff>
<institution content-type="department">Department of Neurology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust</institution>, Birmingham B15 2WB, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6314-4437</contrib-id><name name-style="western"><surname>Mollan</surname><given-names initials="SP">Susan P</given-names></name><degrees>MBChB</degrees><aff>
<institution content-type="department">Translational Brain Science, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham</institution>, Birmingham B15 2TT, <country country="GB">UK</country></aff><aff>
<institution content-type="department">Department of Ophthalmology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust</institution>, Birmingham B15 2GW, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wilson</surname><given-names initials="DR">Duncan R</given-names></name><degrees>MBChB</degrees><aff>
<institution content-type="department">Defence Medical Directorate (Research &amp; Clinical Innovation), HQ DMS Group</institution>, Lichfield WS14 9PY, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8713-2457</contrib-id><name name-style="western"><surname>Lucas</surname><given-names initials="SJE">Samuel J E</given-names></name><degrees>PhD</degrees><aff>
<institution content-type="department">School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham</institution>, Birmingham B15 2TT, <country country="GB">UK</country></aff><aff>
<institution content-type="department">Centre for Human Brain Health, University of Birmingham</institution>, Birmingham B15 2TT, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6785-9352</contrib-id><name name-style="western"><surname>Mitchell</surname><given-names initials="JL">James L</given-names></name><degrees>PhD</degrees><aff>
<institution content-type="department">Translational Brain Science, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham</institution>, Birmingham B15 2TT, <country country="GB">UK</country></aff><aff>
<institution content-type="department">Department of Neurology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust</institution>, Birmingham B15 2WB, <country country="GB">UK</country></aff><aff>
<institution content-type="department">Academic Department of Military Rehabilitation, Defense Medical Rehabilitation Centre, Stanford Hall</institution>, Loughborough LE12 5QW, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8431-7029</contrib-id><name name-style="western"><surname>Hill</surname><given-names initials="LJ">Lisa J</given-names></name><degrees>PhD</degrees><aff>
<institution content-type="department">Translational Brain Science, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham</institution>, Birmingham B15 2TT, <country country="GB">UK</country></aff><aff>
<institution content-type="department">School of Biomedical Sciences, Institute of Clinical Sciences, University of Birmingham</institution>, Birmingham B15 2TT, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2777-5132</contrib-id><name name-style="western"><surname>Sinclair</surname><given-names initials="AJ">Alexandra J</given-names></name><degrees>PhD</degrees><aff>
<institution content-type="department">Translational Brain Science, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham</institution>, Birmingham B15 2TT, <country country="GB">UK</country></aff><aff>
<institution content-type="department">Department of Neurology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust</institution>, Birmingham B15 2WB, <country country="GB">UK</country></aff><on-behalf-of>on behalf of the UK mTBI Predict Consortium</on-behalf-of></contrib></contrib-group><author-notes><fn id="FT0001"><p>The views expressed are those of the authors and not necessarily those of the UK National Health Service, MoD, NIHR, or the UK department of Health and Social Care.</p><p>
<bold>Military Authors</bold>: Lieutenant Colonel James L. Mitchell, Royal Army Medical Corps, Army Medical Services; Brigadier Duncan R. Wilson, Royal Army Medical Corps, Defence Medical Services.</p></fn></author-notes><pub-date pub-type="collection"><season>Jan-Feb</season><year>2025</year></pub-date><pub-date pub-type="epub" iso-8601-date="2024-07-19"><day>19</day><month>7</month><year>2024</year></pub-date><volume>190</volume><issue>1-2</issue><issue-id pub-id-type="pmc-issue-id">479736</issue-id><fpage>e90</fpage><lpage>e98</lpage><history><date date-type="received"><day>22</day><month>4</month><year>2024</year></date><date date-type="rev-recd"><day>20</day><month>6</month><year>2024</year></date><date date-type="accepted"><day>10</day><month>7</month><year>2024</year></date><date date-type="editorial-decision"><day>21</day><month>6</month><year>2024</year></date><date date-type="corrected-typeset"><day>19</day><month>7</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>19</day><month>07</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>17</day><month>01</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-04-26 14:25:40.080"><day>26</day><month>04</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>© The Association of Military Surgeons of the United States 2024.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site–for further information please contact journals.permissions@oup.com.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="usae353.pdf"><?pdf-name usae353.pdf?><?pdf-size 17978502?><?pdf-md5 5ad6d613c43f1e085a6632101840fbcc?><?pdf-image-server-status NEVER_LOAD?><?pdf-cloudpmc-urn urn:app:1896/11737321/5ad6d613c43f/usae353.pdf?></self-uri><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="usae353.pdf"/><abstract><title>ABSTRACT</title><sec id="s1"><title>Introduction</title><p>Mild traumatic brain injury (TBI) affects a significant number of military personnel, primarily because of physical impact, vehicle incidents, and blast exposure. Post-traumatic headache (PTH) is the most common symptom reported following mild TBI and can persist for several years. However, the current International Classification of Headache Disorders lacks phenotypic characterization for this specific headache disorder. It is important to appropriately classify the headache sub-phenotypes as it may enable more targeted management approaches. This systematic review seeks to identify the most common sub-phenotype of headaches in military personnel with PTH attributed to mild TBI.</p></sec><sec id="s2"><title>Methods</title><p>We conducted a systematic search following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses reporting guidelines, focusing on the military population. PubMed, Web of Science, Cochrane, and Clinicaltrials.gov databases were searched. Abstracts and full texts were independently reviewed by two authors using predefined inclusion and exclusion criteria. Data extraction was performed using a standardized form. The risk of bias was assessed using the Newcastle-Ottawa Scale.</p></sec><sec id="s3"><title>Results</title><p>Eight papers related to the military population were included in this review. Migraine was the most commonly reported headache sub-phenotype, with a prevalence ranging from 33 to 92%. Additionally, one military study identified tension-type headaches as the most prevalent headache phenotype. Although not the primary phenotype, one military cohort reported that approximately one-third of their cohort experienced trigeminal autonomic cephalalgias, which were associated with exposure to blast injuries and prior concussions.</p></sec><sec id="s4"><title>Conclusion</title><p>This systematic review demonstrated that PTH in the military population frequently exhibit migraine-like features. Tension-type headache and trigeminal autonomic cephalalgias also occur, although less commonly reported. Sub-phenotyping PTH may be important for initiating effective treatment since different phenotypes may respond differently to medications. The study populations analyzed in this systematic review display heterogeneity, underscoring the necessity for additional research features, more stringent criteria and comprehensive recording of baseline characteristics. Characterizing headaches following injury is crucial for an accurate diagnosis to enable effective management and rehabilitation planning for our armed forces.</p></sec></abstract><funding-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>National Institute for Health and Care Research</institution><institution-id institution-id-type="DOI">10.13039/501100000272</institution-id></institution-wrap>
</funding-source></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Association of British Neurologists</institution></institution-wrap>
</funding-source></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Guarantors of Brain</institution><institution-id institution-id-type="DOI">10.13039/501100000627</institution-id></institution-wrap>
</funding-source></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Sir Jules Thorn Charitable Trust</institution><institution-id institution-id-type="DOI">10.13039/501100000282</institution-id></institution-wrap>
</funding-source></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Ministry of Defence</institution><institution-id institution-id-type="DOI">10.13039/501100006083</institution-id></institution-wrap>
</funding-source></award-group></funding-group><funding-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>National Institute for Health and Care Research</institution><institution-id institution-id-type="DOI">10.13039/501100000272</institution-id></institution-wrap>
</funding-source></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Association of British Neurologists</institution></institution-wrap>
</funding-source></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Guarantors of Brain</institution><institution-id institution-id-type="DOI">10.13039/501100000627</institution-id></institution-wrap>
</funding-source></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Sir Jules Thorn Charitable Trust</institution><institution-id institution-id-type="DOI">10.13039/501100000282</institution-id></institution-wrap>
</funding-source></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Ministry of Defence</institution><institution-id institution-id-type="DOI">10.13039/501100006083</institution-id></institution-wrap>
</funding-source></award-group></funding-group><counts><page-count count="9"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY-NC</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s5"><title>INTRODUCTION</title><p>Traumatic brain injury (TBI) refers to an alteration in brain function or other evidence of brain pathology caused by an external force.<sup><xref rid="R1" ref-type="bibr">1</xref></sup> In England and Wales, head injuries account for approximately 1.4 million hospital visits annually, with around 200,000 resulting in admissions.<sup><xref rid="R2" ref-type="bibr">2</xref></sup> The incidence of mTBI among military personnel is substantial. Within deployed UK military personnel, the estimated prevalence of mild traumatic brain injury (mTBI) is 4.4%, rising to 9.5% for those in combat roles.<sup><xref rid="R3" ref-type="bibr">3</xref></sup> In comparison, the U.S. military reported a prevalence ranging between 12% and 23%.<sup><xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R5" ref-type="bibr">5</xref></sup> Blast injuries, specifically, are the most frequent mechanism of injury, having been particularly prevalent in the wars in Iraq and Afghanistan.<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R6" ref-type="bibr">6</xref></sup> The U.S. Government has acknowledged the significance of mTBI and established the Traumatic Brain Injury Center of Excellence, which has developed specific clinical recommendations and educational tools.<sup><xref rid="R7" ref-type="bibr">7</xref></sup></p><p>Post-traumatic headache (PTH) is a common consequence of mTBI, and has been the subject of increasing investigation.<sup><xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R9" ref-type="bibr">9</xref></sup> The reported incidence of PTH attributed to mTBI varies, ranging from 16% to 79% at three months,<sup><xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R10" ref-type="bibr">10–12</xref></sup> and 15% to 58% at one year in both civilian and military cohorts.<sup><xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R13" ref-type="bibr">13</xref></sup> In a large U.S. military study, the incidence of PTH was at the lower end of this range, at 16% to 27% at three months, and 20% to 28% at 12 months.<sup><xref rid="R10" ref-type="bibr">10</xref></sup> Although studies vary in their methodology, it may be that the lower incidence in U.S. cohorts is that they observe participants of a younger age and have better access to protective equipment.<sup><xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R15" ref-type="bibr">15</xref></sup> According to the International Classification of Headache Disorders, 3rd edition (ICHD-3), PTH is defined as a new or worsening headache attributed to head injury and occurring within seven days of trauma, after regaining consciousness or recovering the ability to sense and report pain.<sup><xref rid="R16" ref-type="bibr">16</xref></sup> Post-traumatic headache can occur in isolation or as part of post-concussion syndrome, which can include dizziness, fatigue, sleep disturbances, mood changes, and impaired cognition.<sup><xref rid="R17" ref-type="bibr">17</xref></sup> Post-traumatic headache can be classified as acute if the headache resolves within 3 months or persistent if it persists beyond three months.<sup><xref rid="R16" ref-type="bibr">16</xref></sup></p><p>When examining the pathophysiology of mTBI and PTH, the impact of mechanical force on the brain disrupts cellular homeostasis, setting off a complex cascade of neurochemical and neurometabolic alterations.<sup><xref rid="R17" ref-type="bibr">17</xref></sup> The pathophysiology of PTH involves several proposed theories, which are likely multifaceted and overlapping in nature. One such theory suggests impaired descending modulation, supported by findings from Schwedt et al., who observed structural differences in cortical thickness without changes in cerebral volume among PTH patients compared to healthy controls, potentially stemming from diffuse axonal injury following TBI.<sup><xref rid="R18" ref-type="bibr">18</xref></sup> Additionally, cortical spreading depression, a phenomenon observed during migraine auras, has been linked to secondary injury mechanisms following TBI.<sup><xref rid="R19" ref-type="bibr">19</xref></sup> Moreover, the neuroinflammatory response subsequent to TBI may activate the trigeminal sensory system, a key player in migraine pathogenesis, further implicating its role in the development of PTH.<sup><xref rid="R17" ref-type="bibr">17</xref></sup></p><p>The clinical characteristics of PTH have been extensively studied and evidence has emerged that clinical features often resemble those of primary headache disorders.<sup><xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R21" ref-type="bibr">21</xref></sup> It is important to appropriately classify the headache sub-phenotypes as it may enable more targeted management approaches.<sup><xref rid="R22" ref-type="bibr">22</xref></sup> To date, a systematic review specifically focusing on phenotyping PTH in the military population has not been conducted. Thus, the aim of this review was to determine the most common headache sub-phenotype among individuals with PTH attributed to mTBI in the military population.</p></sec><sec id="s6"><title>METHODS</title><sec id="s6-s1"><title>Search Criteria</title><p>This systematic review was carried out in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) reporting guidelines.<sup><xref rid="R23" ref-type="bibr">23</xref></sup> A systematic search was performed focusing on PTH phenotype following mTBI in military personnel. Two reviewers (H.S.L. and M.S.) from the University of Birmingham independently screened the abstracts retrieved from the above-mentioned searches using Rayyan software.<sup><xref rid="R24" ref-type="bibr">24</xref></sup> Any discrepancies were resolved through a third senior author (J.M.). The names of authors and journals were not masked from the reviewers. Following abstract review based on the inclusion criteria, selected articles underwent full-text review by two reviewers (H.S.L. and M.S.) working independently. Additionally, the reference lists of these selected articles were searched to identify additional articles that potentially met the inclusion criteria and were subject to the same review process.</p></sec><sec id="s6-s2"><title>Methods for Inclusion</title><p>The search criteria for this systematic review included peer-reviewed and published studies meeting the following criteria: (1) military population active personnel; (2) participants aged 18 years or older; (3) participants diagnosed with mTBI or concussion; (4) participants experiencing subsequent PTH; (5) studies published from inception until March 1, 2023; and (5) studies written in the English language. Searches were conducted in PubMed, Web of Science, Cochrane, and Clinicaltrials.gov. A complete list of the search terms for each database is provided in <xref rid="s10" ref-type="sec">Supplemental Table S1</xref>.</p></sec><sec id="s6-s3"><title>Exclusion Criteria</title><p>Reviews, commentaries, editorials, conference proceedings, case reports, and case series (defined as studies involving fewer than four participants) were excluded. Studies in which PTH was not defined as an outcome or did not include PTH sub-phenotypes were also excluded.</p></sec><sec id="s6-s4"><title>Data Extraction and Outcome Results</title><p>Data extraction was independently performed by the two reviewers (H.S.L. and M.S.) using a standardized form (<xref rid="s10" ref-type="sec">Supplemental Table S2</xref>). Any discrepancies were discussed and resolved between the two investigators, with a senior researcher (J.M.) serving as moderator. Mixed cohort studies were also included in the analysis.<sup><xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R26" ref-type="bibr">26</xref></sup></p></sec><sec id="s6-s5"><title>Assessment of Strength of Evidence</title><p>Each selected study was independently assessed by two investigators (H.S.L. and M.S.) to determine the strength of evidence. The level of evidence was classified and scored based on a modified version of the Newcastle-Ottawa scale.<sup><xref rid="R27" ref-type="bibr">27</xref></sup> A quality assessment rating of “high” (corresponding to ≥7 scores), “medium” (score 6), or “low” (≤5 scores) was assigned to each study.</p></sec></sec><sec id="s7"><title>RESULTS</title><sec id="s7-s1"><title>Resulting Articles and Risk of Bias</title><p>The military search initially yielded 719 articles (<xref rid="F1" ref-type="fig">Figure 1</xref>). Following the screening of abstracts, 13 articles met the inclusion criteria and underwent a full-text review. Upon completion of full-text review, eight military studies<sup><xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R28" ref-type="bibr">28–33</xref></sup> satisfied the final criteria. The methodological risk of bias for each study is reported in <xref rid="s10" ref-type="sec">Supplemental Table S3</xref>; The Newcastle-Ottawa scores ranged from five to seven (mean 6.1).<sup><xref rid="R27" ref-type="bibr">27</xref></sup></p><fig position="float" id="F1" fig-type="figure" orientation="portrait"><label>Figure 1.</label><caption><p>PRISMA flow diagram.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="usae353f1.jpg"><?image-name usae353f1.jpg?><?image-size 73174?><?image-md5 674b4dfa9ca72795e20905c437bd66b4?><?image-image-server-status NEVER_LOAD?><?image-original-height 478?><?image-original-width 750?><?image-scaled-height 478?><?image-scaled-width 750?><?image-cloudpmc-urn urn:cdn:blobs/1896/11737321/674b4dfa9ca7/usae353f1.jpg?><?thumb-name usae353f1.gif?><?thumb-size 3752?><?thumb-md5 d9987c591aa18f2d483b29a32a3328a6?><?thumb-image-server-status NEVER_LOAD?><?thumb-scaled-height 80?><?thumb-scaled-width 125?><?thumb-cloudpmc-urn urn:cdn:blobs/1896/11737321/d9987c591aa1/usae353f1.gif?></graphic></fig></sec><sec id="s7-s2"><title>Baseline Characteristics</title><p>An overview of the studies included is displayed in <xref rid="s10" ref-type="sec">Supplemental Table S4</xref>. Half of the military studies had a prospective design,<sup><xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R31" ref-type="bibr">31</xref>,<xref rid="R33" ref-type="bibr">33</xref></sup> while the other half were retrospective.<sup><xref rid="R28" ref-type="bibr">28–30</xref>,<xref rid="R32" ref-type="bibr">32</xref></sup> Two studies did not define their population as “military” but included a large proportion of blast injury, 43% to 44%,<sup><xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R26" ref-type="bibr">26</xref></sup> and therefore given that blast injuries predominantly occur among military personnel, they have been included in the analysis. Six studies focused on soldiers in active duty, with three studies specifying that their cohorts had recently returned from deployment.<sup><xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R29" ref-type="bibr">29</xref>,<xref rid="R33" ref-type="bibr">33</xref></sup> The duration of these deployments were typically one year, and two studies evaluated participants within seven days of injury.<sup><xref rid="R31" ref-type="bibr">31</xref>,<xref rid="R32" ref-type="bibr">32</xref></sup> The two mixed cohort studies observed those with persistent PTH, with a mean average time of assessment post-injury at 10.6 years.<sup><xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R26" ref-type="bibr">26</xref></sup></p><p>In terms of sex distribution, female participants accounted for 0% to 10% of the exclusive military cohorts, with 32 to 35% reported in the mixed cohort studies.<sup><xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R26" ref-type="bibr">26</xref></sup> Blast injuries were a unique aspect of military personnel, comprising 31% to 92% of the reported injuries.</p><p>Although most studies phenotype headache using the ICHD, the definition of mTBI, however, varied across the studies, with some employing the criteria set by the VA/DoD,<sup><xref rid="R34" ref-type="bibr">34</xref></sup> Centers for Disease Control and Prevention (CDC),<sup><xref rid="R35" ref-type="bibr">35</xref></sup> or no specific criteria. Regarding family history of primary headaches, it was reported in 28% to 32% of the studies,<sup><xref rid="R30" ref-type="bibr">30</xref>,<xref rid="R32" ref-type="bibr">32</xref>,<xref rid="R36" ref-type="bibr">36</xref></sup> with six studies including participants with previous concussions, which affected 18% to 79% of the cohorts.<sup><xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R29" ref-type="bibr">29</xref>,<xref rid="R30" ref-type="bibr">30</xref>,<xref rid="R32" ref-type="bibr">32</xref>,<xref rid="R33" ref-type="bibr">33</xref></sup> Three studies excluded participants with pre-existing headaches.<sup><xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R31" ref-type="bibr">31</xref></sup></p></sec><sec id="s7-s3"><title>Headache Phenotype</title><p>The headache phenotypes are shown in <xref rid="T1" ref-type="table"><bold>Table 1</bold></xref>.</p><table-wrap position="float" id="T1" orientation="landscape"><label>Table 1.</label><caption><p>Military Studies PTH Phenotypes</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1"> </th><th valign="bottom" align="left" rowspan="1" colspan="1"> </th><th valign="bottom" colspan="5" align="center" rowspan="1">Headache phenotypes <italic toggle="yes">N</italic> (%)</th></tr><tr><th valign="bottom" align="left" rowspan="1" colspan="1">First author (year)</th><th valign="bottom" align="left" rowspan="1" colspan="1">Mean time after injury</th><th valign="bottom" align="left" rowspan="1" colspan="1">Migraine</th><th valign="bottom" align="left" rowspan="1" colspan="1">Probable migraine</th><th valign="bottom" align="left" rowspan="1" colspan="1">TTH</th><th valign="bottom" align="left" rowspan="1" colspan="1">TAC</th><th valign="bottom" align="left" rowspan="1" colspan="1">Other headaches</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Chong (2021)</td><td align="left" rowspan="1" colspan="1">10.6  years</td><td align="left" rowspan="1" colspan="1">37 (77)</td><td align="left" rowspan="1" colspan="1">9 (19)</td><td align="left" rowspan="1" colspan="1">2 (4)</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">X</td></tr><tr><td align="left" rowspan="1" colspan="1">Metti (2020)<xref rid="T0001-fn3" ref-type="table-fn"><sup>a</sup></xref></td><td align="left" rowspan="1" colspan="1">Within 1 year</td><td align="left" rowspan="1" colspan="1">76 (33) total<break/> 18) with aura<break/> 34 (15) without aura</td><td align="left" rowspan="1" colspan="1">X</td><td colspan="3" align="left" rowspan="1">“other headaches” 148 (64.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">Howard (2018)</td><td align="left" rowspan="1" colspan="1">10.56 years</td><td colspan="2" align="left" rowspan="1">49 (88)</td><td align="left" rowspan="1" colspan="1">6 (11)</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">Unclassified 1 (2)</td></tr><tr><td align="left" rowspan="1" colspan="1">Finkel (2017)<xref rid="T0001-fn4" ref-type="table-fn"><sup>b</sup></xref></td><td align="left" rowspan="1" colspan="1">27.6 months</td><td align="left" rowspan="1" colspan="1">55 (33)<break/>Mixed migraine-TTH 31 (19)</td><td align="left" rowspan="1" colspan="1">3 (12)</td><td align="left" rowspan="1" colspan="1">31 (19)</td><td align="left" rowspan="1" colspan="1">Hemicrania continua 12 (7)<break/>Cluster 6 (4)<break/>Probable TAC 4 (2)</td><td align="left" rowspan="1" colspan="1">Primary stabbing headache 3 (2)<break/>Primary exertional headache 1 (1)<break/>Secondary headaches 6 (4)<break/>Cranial neuralgia and central causes of facial pain 9 (5)<break/>Unclassifiable 5 (3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Jouzdani (2014)</td><td align="left" rowspan="1" colspan="1">90 - 100 days</td><td align="left" rowspan="1" colspan="1">7 (39)</td><td align="left" rowspan="1" colspan="1">5 (28)</td><td colspan="3" align="left" rowspan="1">“Non-migraine” 6 (33)</td></tr><tr><td align="left" rowspan="1" colspan="1">Finkel (2012)<xref rid="T0001-fn4" ref-type="table-fn"><sup>b</sup></xref></td><td align="left" rowspan="1" colspan="1">25.3 months</td><td colspan="2" align="left" rowspan="1">23 (92)</td><td valign="top" align="left" rowspan="1" colspan="1">14 (56)</td><td align="left" rowspan="1" colspan="1">Hemicrania continua 3 (12)<break/>Trigeminal neuralgia 2 (8)<break/>Cluster headache 2/55 (8)<break/>Paroxysmal hemicrania 1 (4)<break/>SUNA 1 (4)</td><td align="left" rowspan="1" colspan="1">Primary stabbing headache 4 (16)<break/>Headache attributed to disorder of the neck 2 (8)<break/>Supraorbital neuralgia 1 (4)<break/>Attributed to low CSF pressure 1 (4)<break/>Attribute to TMJ disorder 1 (4)</td></tr><tr><td align="left" rowspan="1" colspan="1">Theeler (2010)</td><td align="left" rowspan="1" colspan="1">Approx 1 year</td><td align="left" rowspan="1" colspan="1">210 (58)</td><td align="left" rowspan="1" colspan="1">113 (31)</td><td colspan="3" align="left" rowspan="1">Other headache 38 (10)</td></tr><tr><td align="left" rowspan="1" colspan="1">Theeler (2009)<xref rid="T0001-fn4" ref-type="table-fn"><sup>b</sup></xref></td><td align="left" rowspan="1" colspan="1">Approx 1 year</td><td align="left" rowspan="1" colspan="1">23 (69)<break/>15 (45) migraine without aura<break/>8 (24) migraine with aura</td><td align="left" rowspan="1" colspan="1">3 (9)</td><td align="left" rowspan="1" colspan="1">5 (15)</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">Occipital neuralgia 5 (15)<break/>MOH 4 (12)<break/>NOS 7 (21)</td></tr></tbody></table><table-wrap-foot><fn id="T0001-fn1"><p>CSF, cerebrospinal fluid; MOH, medication overuse headache; NOS, headache not otherwise specified; SUNA, short-lasting unilateral neuralgiform headaches with cranial autonomic symptoms; TMJ, temporomandibular joint; X, not included in study.</p></fn><fn id="T0001-fn2"><p>Chronic daily headache defined as 15 or more headache days per month for the previous 3 months.</p></fn><fn id="T0001-fn3"><label>a</label><p>The percentage values for Metti et al. do not add up to 100% as they had 2.6% with no headache but were later judged to have PTH.</p></fn><fn id="T0001-fn4"><label>b</label><p>Theeler et al. (2009), had a total of 57 headaches for 33 participants. Finkel et al. (2012) reported 55 headaches for 25 participants. Finkel et al. (2017) reported 166 headaches for 95 participants. Percentages are as a portion of the total participants so may not be equal to 100%.</p></fn></table-wrap-foot></table-wrap><p>In three studies, participants were allowed to report multiple headache types,<sup><xref rid="R29" ref-type="bibr">29</xref>,<xref rid="R30" ref-type="bibr">30</xref>,<xref rid="R32" ref-type="bibr">32</xref></sup> with up to 30% of participants reporting multiple headache types.<sup><xref rid="R29" ref-type="bibr">29</xref></sup> Migraine-like was the most common headache sub-phenotype in seven studies, ranging from 33% to 92% of participants.<sup><xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R29" ref-type="bibr">29–32</xref></sup> However, one study reported lower numbers, with 33% of participants suffering from migraine-like and 64% classified as “other headaches.”<sup><xref rid="R33" ref-type="bibr">33</xref></sup> Different studies had varying approaches to categorizing migraine-like and probable migraine-like, with some treating them as distinct phenotypes,<sup><xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R29" ref-type="bibr">29</xref>,<xref rid="R31" ref-type="bibr">31</xref>,<xref rid="R32" ref-type="bibr">32</xref></sup> while others combined them,<sup><xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R30" ref-type="bibr">30</xref></sup> or did not provide information on probable migraine-like at all.<sup><xref rid="R33" ref-type="bibr">33</xref></sup> Five of the included studies further separated “non-migrainous” headaches into other primary headache phenotypes.<sup><xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R29" ref-type="bibr">29</xref>,<xref rid="R30" ref-type="bibr">30</xref>,<xref rid="R32" ref-type="bibr">32</xref></sup> Tension-type headache (TTH)-like was the second most common headache sub-phenotype in four studies.<sup><xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R29" ref-type="bibr">29</xref>,<xref rid="R30" ref-type="bibr">30</xref>,<xref rid="R32" ref-type="bibr">32</xref></sup> There were 13% to 36% of participants with trigeminal autonomic cephalalgias (TACs) in two studies (same cohort), with blast injuries and prior concussions being contributing factors.<sup><xref rid="R30" ref-type="bibr">30</xref>,<xref rid="R32" ref-type="bibr">32</xref></sup> A study comparing mTBI cohorts with healthy controls found that those with PTH had predominantly migrainous features, and specific symptoms strongly associated with PTH included visual or sensory aura, allodynia, and daily or continuous headaches.<sup><xref rid="R33" ref-type="bibr">33</xref></sup> The headache assessments in the eight studies involved a variety of professionals, including neurologist/headache specialist,<sup><xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R29" ref-type="bibr">29</xref>,<xref rid="R30" ref-type="bibr">30</xref>,<xref rid="R32" ref-type="bibr">32</xref></sup> and healthcare professionals in an emergency department.<sup><xref rid="R31" ref-type="bibr">31</xref></sup> Self-administered questionnaires were also used in some studies.<sup><xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R33" ref-type="bibr">33</xref></sup></p><p>Additional headache characteristics were reported in <xref rid="T2" ref-type="table"><bold>Table 2</bold></xref>. In the seven military studies that reported monthly headache days (MHDs), the mean range was 9.9 to 26.7 MHD.<sup><xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R29" ref-type="bibr">29</xref>,<xref rid="R30" ref-type="bibr">30</xref>,<xref rid="R32" ref-type="bibr">32</xref>,<xref rid="R33" ref-type="bibr">33</xref></sup> Most headaches lasted more than four hours and had a moderate to severe severity.<sup><xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R29" ref-type="bibr">29</xref>,<xref rid="R30" ref-type="bibr">30</xref>,<xref rid="R32" ref-type="bibr">32</xref>,<xref rid="R33" ref-type="bibr">33</xref></sup></p><table-wrap position="float" id="T2" orientation="portrait"><label>Table 2.</label><caption><p>Additional Headache Characteristics</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Study</th><th valign="bottom" align="left" rowspan="1" colspan="1">Headache onset</th><th valign="bottom" align="left" rowspan="1" colspan="1">Mean headache days per month</th><th valign="bottom" align="left" rowspan="1" colspan="1">Mean headache duration (hours)</th><th valign="bottom" align="left" rowspan="1" colspan="1">Mean headache severity</th><th valign="bottom" align="left" rowspan="1" colspan="1">Return to work outcomes</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Chong (2021)</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">16.1 (SD 8.4)</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">X</td></tr><tr><td align="left" rowspan="1" colspan="1">Metti (2020)</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">15 (SD 10)</td><td align="left" rowspan="1" colspan="1">9.4 (SD 20.4)</td><td align="left" rowspan="1" colspan="1">6.8 (2.0) (0–10 pain scale)</td><td align="left" rowspan="1" colspan="1">X</td></tr><tr><td align="left" rowspan="1" colspan="1">Howard (2018)</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">16.2</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">X</td></tr><tr><td align="left" rowspan="1" colspan="1">Finkel (2017)<xref rid="T0002-fn3" ref-type="table-fn"><sup>a</sup></xref></td><td align="left" rowspan="1" colspan="1">≤7 days 73 (76.8%)<break/>8-30 days 7 (7.4%)<break/>1-3 months 2 (2.1%)<break/>3-6 months 1 (1%)<break/>&gt;3 months 3 (3.2%)<break/>Unknown 9 (9.5%)</td><td align="left" rowspan="1" colspan="1">26.7 (SD 6.8)</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">16.9 (SD 9.7) headache severe days</td><td align="left" rowspan="1" colspan="1">71 (74.7%) retired<break/> 52 (66.7%) had positive MEB and were discharged/retired<break/>24 (25.3%) continued active duty</td></tr><tr><td align="left" rowspan="1" colspan="1">Finkel (2012)<xref rid="T0002-fn3" ref-type="table-fn"><sup>a</sup></xref></td><td align="left" rowspan="1" colspan="1">92% of soldiers &lt;1 week<break/>65.4% of all headache types &lt;1 week<break/>9% began after 1 month<break/>No headaches started after 3 months</td><td align="left" rowspan="1" colspan="1">15.7</td><td align="left" rowspan="1" colspan="1">31% lasted less than 4  hours</td><td align="left" rowspan="1" colspan="1">Moderate to severe</td><td align="left" rowspan="1" colspan="1">X</td></tr><tr><td align="left" rowspan="1" colspan="1">Theeler (2010)</td><td align="left" rowspan="1" colspan="1">&lt;1 week 361<break/>1–4 weeks 187<break/>&gt;1 month 409</td><td align="left" rowspan="1" colspan="1">9.9</td><td align="left" rowspan="1" colspan="1">4.5</td><td align="left" rowspan="1" colspan="1">5.7 (0–10 pain scale)</td><td align="left" rowspan="1" colspan="1">134 (37%) with decreased activity days.<break/>16 (4%) with missed workdays<break/>42 (11%) with sick call visits</td></tr><tr><td align="left" rowspan="1" colspan="1">Theeler (2009)</td><td align="left" rowspan="1" colspan="1">&lt;1 week 12 (36%)<break/>1–4 weeks 1 (3%)<break/>&gt;1 month 3 (9%)<break/>Unspecified onset 5 (15%)<break/>Worsening of pre-existing headache 12 (36%)</td><td align="left" rowspan="1" colspan="1">14.5 ±11.7 during deployment<break/>11.9 ±10.0 after deployment</td><td align="left" rowspan="1" colspan="1">8.8 ±7.3</td><td align="left" rowspan="1" colspan="1">7.1 ± 1.5 (0–10 pain scale)</td><td align="left" rowspan="1" colspan="1">Mean MIDAS 30.8 ± 44.3</td></tr></tbody></table><table-wrap-foot><fn id="T0002-fn1"><p>MEB, medical evaluation board; MIDAS, migraine disability assessment score; X, not reported.</p></fn><fn id="T0002-fn2"><p>Table does not include studies that do not have this information i.e., Jouzdani (2014).</p></fn><fn id="T0002-fn3"><label>a</label><p>Using data for headache onset within 1 week of trauma.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="s8"><title>DISCUSSION</title><p>Migraine was found to be a common headache phenotype following mTBI; however, there was a wide range of reported prevalence rates. Tension type headache was also reported as a prevalent headache phenotype. Interestingly, a proportion of military personnel were diagnosed with TACs, which were associated with exposure to blast injuries and prior concussions. Trigeminal autonomic cephalalgias often have a delayed diagnosis because of a lack of expertise in the recognition of the phenotype, and this underlines the importance of involving neurological expertise in the management of TBI.<sup><xref rid="R37" ref-type="bibr">37</xref></sup></p><p>Most studies used the ICHD to phenotype headaches, either the second<sup><xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R29" ref-type="bibr">29–32</xref></sup> or third<sup><xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R33" ref-type="bibr">33</xref></sup> edition. Both editions define PTH as headache onset within seven days of injury, but there are slight differences in the diagnostic criteria for sub-phenotypes; i.e., migraine, TTH. Both editions omit any further headache characteristics and this is likely a consensus opinion rather than evidence-based.<sup><xref rid="R16" ref-type="bibr">16</xref></sup> It is important to note that the ICHD acknowledge that delayed PTH may present up to three months after injury.<sup><xref rid="R16" ref-type="bibr">16</xref></sup></p><p>In a large U.S.-based study of 3,952 U.S. Army personnel deployed in Iraq, 587 self-reported concussions, with 72.2% reported as blast-related.<sup><xref rid="R38" ref-type="bibr">38</xref></sup> Blast injury has unique physiological and biochemical effects, including primary blast (direct blast wave impact), secondary blast (penetrating/non-penetrating injuries caused by debris or fragments), tertiary blast (body displacement or impact with environment), and quaternary (effects on explosion; i.e., burns) blast effects.<sup><xref rid="R39" ref-type="bibr">39</xref></sup> Given that a migraine-like phenotype is also the main headache phenotype observed among civilians, it could be hypothesized that the modality of injury in mTBI may not play a predominant role in the phenotype of the headache.<sup><xref rid="R36" ref-type="bibr">36</xref></sup> Although there are differences, they share similar underlying mechanistic pathways, including central sensitization, neuroinflammation, and alterations in pain processing pathways.<sup><xref rid="R40" ref-type="bibr">40</xref></sup></p><p>There is a well-established sex disparity among the population of migraine sufferers, with migraine being three to four times more frequent in women than in men.<sup><xref rid="R41" ref-type="bibr">41</xref></sup> Research has also suggested than women reported longer durations of migraine attacks than men.<sup><xref rid="R41" ref-type="bibr">41</xref></sup> Outside of the mixed cohort studies, female participants only accounted for 0% to 10% of available military studies, although there is a 11.3% female representation of the UK Regular Forces (2022)<sup><xref rid="R42" ref-type="bibr">42</xref></sup> and 17.3% Female Active Duty members in the United States (2021).<sup><xref rid="R43" ref-type="bibr">43</xref></sup> Females may be underrepresented in the current literature with studies having an overall average of 3% (44/1,406) mTBI compared to the regular forces representation of 11.3% which may, in part, be because of lower representation in frontline combat.</p><p>There is evidence that migraine and PTH are not pathophysiologically identical. Magnetic resonance imaging (MRI)-based studies have examined differences in the brain between persistent PTH and those with migraine, including cortical thickness, regional volumes, surface area, and both static and dynamic functional connectivity for regions involved in pain processing.<sup><xref rid="R18" ref-type="bibr">18</xref>,<xref rid="R44" ref-type="bibr">44</xref></sup> These studies indicate differing underlying pathophysiology between PTH and migraine, emphasizing the need for more specific characterization of PTH. However patients with persistent PTH, and no pre-existing headache, were shown to develop headache exacerbation with migraine-like features after intravenous infusion of calcitonin gene-related peptide (CGRP).<sup><xref rid="R45" ref-type="bibr">45</xref></sup> However, one study surprisingly found lower CGRP plasma levels in 100 participants with persistent PTH, compared with sex-matched healthy non-headache controls.<sup><xref rid="R46" ref-type="bibr">46</xref></sup> This opposes the consistent observations of elevated plasma and salivary CGRP levels in the interictal phase of those with migraine.<sup><xref rid="R47" ref-type="bibr">47–49</xref></sup></p><p>Sub-phenotyping PTH may be important for initiating effective treatment, since different phenotypes may respond differently to medications.<sup><xref rid="R22" ref-type="bibr">22</xref></sup> Post-traumatic headache is often difficult to treat, which can be related to the heterogenous nature of PTH, and is mostly based on expert consensus.<sup><xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R50" ref-type="bibr">50</xref></sup> Although there are effective treatments for chronic migraine in the general population (i.e., CGRP) for reducing monthly migraine days and acute medication use, it remains to be determined if these can be extrapolated to migraine-like PTH.<sup><xref rid="R51" ref-type="bibr">51</xref></sup> Although management of PTH is not within the scope of this review, it is advised that all patients are offered an oral non-steroid anti-inflammatory, if tolerated, or paracetamol. Additionally, the advice is to not use opiates.<sup><xref rid="R50" ref-type="bibr">50</xref></sup> For those with a migraine-like phenotype they may benefit from a triptan or gepant.<sup><xref rid="R50" ref-type="bibr">50</xref></sup> A review by Ashina et al. (2022) recommended amitriptyline, mirtazapine, and venlafaxine for those with TTH-like phenotype; with amitriptyline, candesartan, or certain beta-blockers for migraine-like phenotype. A U.S. study demonstrated statistically significant improvement in headache frequency, reducing by 4.5 days per month, in a military cohort with chronic PTH after mTBI using Topiramate, when compared to tricyclic antidepressants, propranolol, and valproate.<sup><xref rid="R52" ref-type="bibr">52</xref></sup> There has been increasing evidence highlighting the role of CGRP in PTH, as mentioned above.<sup><xref rid="R45" ref-type="bibr">45</xref></sup> A more recent open-label trial indicated that those with persistent PTH may benefit from erenumab (monoclonal antibody against CGRP receptor), with the mean MHDs of moderate-to-severe intensity reducing by 2.8 days from 15.7 days at baseline to week 9 through to 12, but was not compared to placebo or alternative treatment.<sup><xref rid="R53" ref-type="bibr">53</xref></sup></p><sec id="s8-s1"><title>Limitations</title><p>We were unable to perform a meta-analysis of these results because of substantial heterogeneity highlighted above, and instead provided a narrative description of the findings. This review has highlighted that characterizing PTH in deployed military personnel faces several challenges. When looking at the variability in Newcastle-Ottawa scores, two studies received a score of five (high risk of bias),<sup><xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R26" ref-type="bibr">26</xref></sup> which raises concerns regarding its methodological limitations and potential biases. Some of the included studies lacked documentation of participants’ baseline characteristics regarding pre-existing headache disorders, which are known to be associated with the development of PTH.<sup><xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R33" ref-type="bibr">33</xref></sup> Notably, three studies explicitly excluded patients with pre-existing headaches before their head injury.<sup><xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R31" ref-type="bibr">31</xref></sup> Since PTH can also be defined as the worsening of pre-existing headaches, excluding this sub-cohort of patients could introduce selection bias. This, in turn, can alter study outcomes, such as the sub-phenotype of PTH. Conversely, a review article argues that including those with pre-existing headaches is unlikely to represent the prevalence rates of the general population, thus limiting generalizability.<sup><xref rid="R54" ref-type="bibr">54</xref></sup> This discrepancy underscores the importance of careful study design to balance the accurate representation of PTH characteristics and the generalizability of findings to the broader population. Additionally, there is the risk of recall bias because of assessments being conducted after their return from operations, along with possible cognitive disturbances associated with wider post-concussion syndrome. This bias extends not only to the timing of headache onset but also to the accurate identification of the injury as a mTBI. It is important to note that the military participants were usually assessed within a year of injury, whereas the mixed cohorts included individuals up to 11 years post injury. Limited participation of females in military studies poses a potential limitation in generalizing the findings to the broader population. It is important to acknowledge there may be variability in blast injury severity within the category of mTBI. The use of different professionals for documenting headache phenotypes introduces variability in expertise, training, and consistency, highlighting the need for standardized criteria and protocols to minimize variability and potential bias in the classification of headache phenotypes. In addition, there is some symptom overlap with migraine and TTH, with photophobia, phonophobia and kinesiophobia also being experienced by those with TTH, and this can lead to discrepancy in results.<sup><xref rid="R55" ref-type="bibr">55</xref></sup> The exclusion of probable migraine-like as a phenotype in certain studies raises the possibility that some headaches categorized as “unclassified” may actually meet the criteria for this phenotype, leading to under-reporting of this phenotype. The 2 studies that reported higher numbers of TAC were from the same cohort at different time points and so may not be representative of the wider military cohort.<sup><xref rid="R30" ref-type="bibr">30</xref>,<xref rid="R32" ref-type="bibr">32</xref></sup> While using the term “military” as a population there are many different roles within a military population that may be more susceptible to PTH and mTBI, such as those involved in close combat roles versus those involved in shaping operational environments.</p></sec><sec id="s8-s2"><title>Future Directions</title><p>In future research, we would recommend appropriately recording baseline characteristics, including the presence of any pre-existing headache, family history of headache, and any previous concussion history. It would also be useful to investigate when the headaches started and observe any potential changes in phenotype over time i.e., prospective contemporaneous longitudinal studies. The study populations analyzed in this systematic review display heterogeneity, underscoring the necessity for additional research features, more stringent criteria, and comprehensive recording of baseline characteristics.</p></sec></sec><sec id="s9"><title>CONCLUSION</title><p>Post-traumatic headache among military personnel most commonly presents with migraine-like features, with TTH-like headache being the second most prevalent sub-phenotype. Of note, TACs were more prevalent among one military cohort—potentially because of the modality of injury, pre-existing characteristics, or the headache phenotyping interview itself. Characterization of PTH will allow for better identification of this type of headache. It will lead to targeted therapeutic trials and in turn enable the rehabilitation of our armed forces that suffer mTBI and subsequent PTH.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="sup1" position="float" content-type="local-data" orientation="portrait"><label>usae353_Supp</label><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="usae353_supp.zip" position="float" orientation="portrait"><?suppdata-name usae353_supp.zip?><?suppdata-size 91613?><?suppdata-md5 ba6db349138a0d794c29415ea8553098?><?suppdata-image-server-status NEVER_LOAD?><?suppdata-mime-type application?><?suppdata-mime-sub-type zip?><?suppdata-cloudpmc-urn urn:app:1896/11737321/ba6db349138a/usae353_supp.zip?></media></supplementary-material></sec></body><back><ack id="ack1"><title>ACKNOWLEDGMENTS</title><p>H.L. wrote the manuscript with senior input from J.M., M.S., M.T., S.M., L.J.H., O.G., A.Y., D.W., S.J.E.L., and A.S. Also H.L. and M.S. screened abstracts and full texts and conducted the systematic review. All authors read and approved the final manuscript. The institutional clearance was approved by Ministry of Defence.</p></ack><sec id="s10"><title>SUPPLEMENTARY MATERIAL</title><p>
<xref rid="sup1" ref-type="supplementary-material">Supplementary material</xref> is available at <italic toggle="yes">Military Medicine</italic> online.</p></sec><sec id="s11"><title>FUNDING</title><p>Funded by the UK mTBI Predict consortia grant from the Ministry of Defence.</p><p>M.S., NIHR Academic Clinical Fellow, is funded by the NIHR. The views expressed in this publication are those of the authors and not necessarily those of the NIHR, NHS, or the UK Department of Health and Social Care.</p><p>A.Y. is funded by an Association of British Neurologists and Guarantors of the Brain fellowship.</p><p>A.J.S. is funded by a Sir Jules Thorn Award for Biomedical Science. H.L. is funded by the Ministry of Defence (MoD) as part of mTBI-PREDICT. J.L.M. and D.R.W. are employees of the MoD.</p></sec><sec sec-type="COI-statement" id="s12"><title>CONFLICT OF INTEREST STATEMENT</title><p>A.J.S. reports personal fees from Invex therapeutics in her role as Director with stock holdings, during the conduct of the study; other from Allergan, Novartis, Cheisi and Amgen outside the submitted work.</p><p>S.P.M. has received honoraria for speaker events from Heidelberg engineering; Chugai-Roche Ltd and Teva. Honoraria for advisory boards for Invex Therapeutics, Gensight and ocular therapeutix. Consultancy fees Neurodiem and Invex Therapeutics. Research funding from the UK Space Agency. All declared interested are outside the area of this submitted work.</p><p>A.Y. reports receiving speaker fees from Teva, UK outside the submitted work.</p><p>All other authors declare no competing interests.</p><p>Authors declare no other financial relationships with any organization that might have an interest in the submitted work; and no other relationships or activities that could appear to have influenced the submitted work.</p></sec><sec sec-type="data-availability" id="s13"><title>DATA AVAILABILITY</title><p>No new data were generated or analyzed in support of this research.</p></sec><ref-list id="ref1"><title>REFERENCES</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>McAllister</surname>  <given-names>TW</given-names></string-name>
</person-group>. <article-title>Neurobiological consequences of traumatic brain injury</article-title>. <source><italic toggle="yes">Dialogues Clin Neurosci</italic></source>. <year>2011</year>;<volume>13</volume>(<issue>3</issue>):<fpage>287</fpage>–<lpage>300</lpage>.doi: <pub-id pub-id-type="doi">10.31887/DCNS.2011.13.2/tmcallister</pub-id><pub-id pub-id-type="pmid">22033563</pub-id>
<pub-id pub-id-type="pmcid">PMC3182015</pub-id></mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Davis</surname>  <given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Ings</surname>  <given-names>A</given-names></string-name></person-group>. <article-title>Head injury: triage, assessment, investigation and early management of head injury in children, young people and adults (NICE guideline CG 176)</article-title>. <source><italic toggle="yes">Arch Dis Childhood-E</italic></source>. <year>2015</year>;<volume>100</volume>(<issue>2</issue>):<fpage>97</fpage>–<lpage>100</lpage>.doi: <pub-id pub-id-type="doi">10.1136/archdischild-2014-306797</pub-id><pub-id pub-id-type="pmid">25335757</pub-id></mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Rona</surname>  <given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Jones</surname>  <given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Goodwin</surname>  <given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Hull</surname>  <given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Wessely</surname>  <given-names>S</given-names></string-name></person-group>. <article-title>Risk factors for headache in the UK military: cross-sectional and longitudinal analyses</article-title>. <source><italic toggle="yes">Headache</italic></source>. <year>2013</year>;<volume>53</volume>(<issue>5</issue>):<fpage>787</fpage>–<lpage>98</lpage>.doi: <pub-id pub-id-type="doi">10.1111/head.12101</pub-id><pub-id pub-id-type="pmid">23574030</pub-id>
</mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Schneiderman</surname>  <given-names>AI</given-names></string-name>, <string-name name-style="western"><surname>Braver</surname>  <given-names>ER</given-names></string-name>, <string-name name-style="western"><surname>Kang</surname>  <given-names>HK</given-names></string-name></person-group>. <article-title>Understanding sequelae of injury mechanisms and mild traumatic brain injury incurred during the conflicts in Iraq and Afghanistan: persistent postconcussive symptoms and posttraumatic stress disorder</article-title>. <source><italic toggle="yes">Am J Epidemiol</italic></source>. <year>2008</year>;<volume>167</volume>(<issue>12</issue>):<fpage>1446</fpage>–<lpage>52</lpage>.doi: <pub-id pub-id-type="doi">10.1093/aje/kwn068</pub-id><pub-id pub-id-type="pmid">18424429</pub-id>
</mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Terrio</surname>  <given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Brenner</surname>  <given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Ivins</surname>  <given-names>BJ</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Traumatic brain injury screening: preliminary findings in a US Army Brigade Combat Team</article-title>. <source><italic toggle="yes">J Head Trauma Rehabil</italic></source>. <year>2009</year>;<volume>24</volume>(<issue>1</issue>):<fpage>14</fpage>–<lpage>23</lpage>.doi: <pub-id pub-id-type="doi">10.1097/HTR.0b013e31819581d8</pub-id><pub-id pub-id-type="pmid">19158592</pub-id>
</mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Elder</surname>  <given-names>GA</given-names></string-name>, <string-name name-style="western"><surname>Mitsis</surname>  <given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Ahlers</surname>  <given-names>ST</given-names></string-name>, <string-name name-style="western"><surname>Cristian</surname>  <given-names>A</given-names></string-name></person-group>. <article-title>Blast-induced mild traumatic brain injury</article-title>. <source><italic toggle="yes">Psychiat Clin North Am</italic></source>. <year>2010</year>;<volume>33</volume>(<issue>4</issue>):<fpage>757</fpage>–<lpage>81</lpage>.doi: <pub-id pub-id-type="doi">10.1016/j.psc.2010.08.001</pub-id><pub-id pub-id-type="pmid">21093677</pub-id></mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<collab>DoD</collab>
</person-group>. <article-title>Defense and Veterans Brain Injury Center (DVBIC)</article-title>. <comment>Accessed April 1, 2023</comment>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://hiddenheroes.org/resource/defense-veterans-brain-injury-center-dvbic/" ext-link-type="uri">https://hiddenheroes.org/resource/defense-veterans-brain-injury-center-dvbic/</ext-link>.</mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Lucas</surname>  <given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Hoffman</surname>  <given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Bell</surname>  <given-names>KR</given-names></string-name>, <string-name name-style="western"><surname>Dikmen</surname>  <given-names>S</given-names></string-name></person-group>. <article-title>A prospective study of prevalence and characterization of headache following mild traumatic brain injury</article-title>. <source><italic toggle="yes">Cephalalgia</italic></source>. <year>2014</year>;<volume>34</volume>(<issue>2</issue>):<fpage>93</fpage>–<lpage>102</lpage>.doi: <pub-id pub-id-type="doi">10.1177/0333102413499645</pub-id><pub-id pub-id-type="pmid">23921798</pub-id>
</mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Hoffman</surname>  <given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Lucas</surname>  <given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Dikmen</surname>  <given-names>S</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Natural history of headache after traumatic brain injury</article-title>. <source><italic toggle="yes">J Neurotrauma</italic></source>. <year>2011</year>;<volume>28</volume>(<issue>9</issue>):<fpage>1719</fpage>–<lpage>25</lpage>.doi: <pub-id pub-id-type="doi">10.1089/neu.2011.1914</pub-id><pub-id pub-id-type="pmid">21732765</pub-id>
<pub-id pub-id-type="pmcid">PMC3172878</pub-id></mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Center</surname>  <given-names>AFHS</given-names></string-name>
</person-group>. <article-title>Incident diagnoses of common symptoms (“sequelae”) following traumatic brain injury, active component, U.S. Armed Forces, 2000-2012</article-title>. <year>2013</year>. <comment>Accessed February 1, 2023</comment>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://europepmc.org/article/MED/23819535" ext-link-type="uri">https://europepmc.org/article/MED/23819535</ext-link>.<pub-id pub-id-type="pmid">23819535</pub-id></mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Kraus</surname>  <given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Schaffer</surname>  <given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Ayers</surname>  <given-names>K</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Physical complaints, medical service use, and social and employment changes following mild traumatic brain injury: a 6-month longitudinal study</article-title>. <source><italic toggle="yes">J Head Trauma Rehabil</italic></source>. <year>2005</year>;<volume>20</volume>(<issue>3</issue>):<fpage>239</fpage>–<lpage>56</lpage>.doi: <pub-id pub-id-type="doi">10.1097/00001199-200505000-00007</pub-id><pub-id pub-id-type="pmid">15908824</pub-id>
</mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Faux</surname>  <given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Sheedy</surname>  <given-names>J</given-names></string-name></person-group>. <article-title>A prospective controlled study in the prevalence of posttraumatic headache following mild traumatic brain injury</article-title>. <source><italic toggle="yes">Pain Med</italic></source>. <year>2008</year>;<volume>9</volume>(<issue>8</issue>):<fpage>1001</fpage>–<lpage>11</lpage>.doi: <pub-id pub-id-type="doi">10.1111/j.1526-4637.2007.00404.x</pub-id><pub-id pub-id-type="pmid">18266807</pub-id>
</mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Hoffman</surname>  <given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Lucas</surname>  <given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Dikmen</surname>  <given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Temkin</surname>  <given-names>N</given-names></string-name></person-group>. <article-title>Clinical perspectives on headache after traumatic brain injury</article-title>. <source><italic toggle="yes">Pm R</italic></source>. <year>2020</year>;<volume>12</volume>(<issue>10</issue>):<fpage>967</fpage>–<lpage>74</lpage>.doi: <pub-id pub-id-type="doi">10.1002/pmrj.12338</pub-id><pub-id pub-id-type="pmid">32003524</pub-id>
</mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Theeler</surname>  <given-names>BJ</given-names></string-name>, <string-name name-style="western"><surname>Flynn</surname>  <given-names>FG</given-names></string-name>, <string-name name-style="western"><surname>Erickson</surname>  <given-names>JC</given-names></string-name></person-group>. <article-title>Headaches after concussion in US soldiers returning from Iraq or Afghanistan</article-title>. <source><italic toggle="yes">Headache</italic></source>. <year>2010</year>;<volume>50</volume>(<issue>8</issue>):<fpage>1262</fpage>–<lpage>72</lpage>.doi: <pub-id pub-id-type="doi">10.1111/j.1526-4610.2010.01700.x</pub-id><pub-id pub-id-type="pmid">20553333</pub-id>
</mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Hoge</surname>  <given-names>CW</given-names></string-name>, <string-name name-style="western"><surname>McGurk</surname>  <given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Thomas</surname>  <given-names>JL</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Mild traumatic brain injury in U.S. Soldiers returning from Iraq</article-title>. <source><italic toggle="yes">N Engl J Med</italic></source>. <year>2008</year>;<volume>358</volume>(<issue>5</issue>):<fpage>453</fpage>–<lpage>63</lpage>.doi: <pub-id pub-id-type="doi">10.1056/NEJMoa072972</pub-id><pub-id pub-id-type="pmid">18234750</pub-id>
</mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<collab>IHS</collab>
</person-group>. <article-title>Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition</article-title>. <source><italic toggle="yes">Cephalalgia</italic></source>. <year>2018</year>;<volume>38</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>211</lpage>.doi: <pub-id pub-id-type="doi">10.1177/0333102417738202</pub-id><pub-id pub-id-type="pmid">29368949</pub-id></mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Ashina</surname>  <given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Porreca</surname>  <given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Anderson</surname>  <given-names>T</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Post-traumatic headache: epidemiology and pathophysiological insights</article-title>. <source><italic toggle="yes">Nat Rev Neurol</italic></source>. <year>2019</year>;<volume>15</volume>(<issue>10</issue>):<fpage>607</fpage>–<lpage>17</lpage>.doi: <pub-id pub-id-type="doi">10.1038/s41582-019-0243-8</pub-id><pub-id pub-id-type="pmid">31527806</pub-id>
</mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Schwedt</surname>  <given-names>TJ</given-names></string-name>, <string-name name-style="western"><surname>Chong</surname>  <given-names>CD</given-names></string-name>, <string-name name-style="western"><surname>Peplinski</surname>  <given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ross</surname>  <given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Berisha</surname>  <given-names>V</given-names></string-name></person-group>. <article-title>Persistent post-traumatic headache vs. migraine: an MRI study demonstrating differences in brain structure</article-title>. <source><italic toggle="yes">J Headache Pain</italic></source>. <year>2017</year>;<volume>18</volume>(<issue>1</issue>):<page-range>87</page-range>.doi: <pub-id pub-id-type="doi">10.1186/s10194-017-0796-0</pub-id><pub-id pub-id-type="pmcid">PMC5567584</pub-id><pub-id pub-id-type="pmid">28831776</pub-id></mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Cozzolino</surname>  <given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Marchese</surname>  <given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Trovato</surname>  <given-names>F</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Understanding spreading depression from headache to sudden unexpected death</article-title>. <source><italic toggle="yes">Front Neurol</italic></source>. <year>2018</year>;<volume>9</volume>:<page-range>19</page-range>.doi: <pub-id pub-id-type="doi">10.3389/fneur.2018.00019</pub-id><pub-id pub-id-type="pmcid">PMC5799941</pub-id><pub-id pub-id-type="pmid">29449828</pub-id></mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Theeler</surname>  <given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Lucas</surname>  <given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Riechers</surname>  <given-names>RG</given-names>  <suffix>2nd</suffix></string-name>, <string-name name-style="western"><surname>Ruff</surname>  <given-names>RL</given-names></string-name></person-group>. <article-title>Post-traumatic headaches in civilians and military personnel: a comparative, clinical review</article-title>. <source><italic toggle="yes">Headache</italic></source>. <year>2013</year>;<volume>53</volume>(<issue>6</issue>):<fpage>881</fpage>–<lpage>900</lpage>.doi: <pub-id pub-id-type="doi">10.1111/head.12123</pub-id><pub-id pub-id-type="pmid">23721236</pub-id>
</mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Ashina</surname>  <given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Iljazi</surname>  <given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Al-Khazali</surname>  <given-names>HM</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Persistent post-traumatic headache attributed to mild traumatic brain injury: deep phenotyping and treatment patterns</article-title>. <source><italic toggle="yes">Cephalalgia</italic></source>. <year>2020</year>;<volume>40</volume>(<issue>6</issue>):<fpage>554</fpage>–<lpage>64</lpage>.doi: <pub-id pub-id-type="doi">10.1177/0333102420909865</pub-id><pub-id pub-id-type="pmid">32102546</pub-id>
</mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Ashina</surname>  <given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Eigenbrodt</surname>  <given-names>AK</given-names></string-name>, <string-name name-style="western"><surname>Seifert</surname>  <given-names>T</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Post-traumatic headache attributed to traumatic brain injury: classification, clinical characteristics, and treatment</article-title>. <source><italic toggle="yes">Lancet Neurol</italic></source>. <year>2021</year>;<volume>20</volume>(<issue>6</issue>):<fpage>460</fpage>–<lpage>9</lpage>.doi: <pub-id pub-id-type="doi">10.1016/S1474-4422(21)00094-6</pub-id><pub-id pub-id-type="pmid">34022171</pub-id>
</mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Page</surname>  <given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>McKenzie</surname>  <given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Bossuyt</surname>  <given-names>PM</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</article-title>. <source><italic toggle="yes">BMJ</italic></source>. <year>2021</year>;<volume>372</volume>:<page-range>n71</page-range>.doi: <pub-id pub-id-type="doi">10.1136/bmj.n71</pub-id><pub-id pub-id-type="pmcid">PMC8005924</pub-id><pub-id pub-id-type="pmid">33782057</pub-id></mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Ouzzani</surname>  <given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Hammady</surname>  <given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Fedorowicz</surname>  <given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Elmagarmid</surname>  <given-names>A</given-names></string-name></person-group>. <article-title>Rayyan-a web and mobile app for systematic reviews</article-title>. <source><italic toggle="yes">Syst Rev</italic></source>. <year>2016</year>;<volume>5</volume>(<issue>1</issue>):<page-range>210</page-range>.doi: <pub-id pub-id-type="doi">10.1186/s13643-016-0384-4</pub-id><pub-id pub-id-type="pmcid">PMC5139140</pub-id><pub-id pub-id-type="pmid">27919275</pub-id></mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Chong</surname>  <given-names>CD</given-names></string-name>, <string-name name-style="western"><surname>Berisha</surname>  <given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Ross</surname>  <given-names>K</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Distinguishing persistent post-traumatic headache from migraine: classification based on clinical symptoms and brain structural MRI data</article-title>. <source><italic toggle="yes">Cephalalgia</italic></source>. <year>2021</year>;<volume>41</volume>(<issue>8</issue>):<fpage>943</fpage>–<lpage>55</lpage>.doi: <pub-id pub-id-type="doi">10.1177/0333102421991819</pub-id><pub-id pub-id-type="pmid">33926241</pub-id>
</mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Howard</surname>  <given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Dumkrieger</surname>  <given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Chong</surname>  <given-names>CD</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Symptoms of autonomic dysfunction among those with persistent posttraumatic headache attributed to mild traumatic brain injury: a comparison to migraine and healthy controls</article-title>. <source><italic toggle="yes">Headache</italic></source>. <year>2018</year>;<volume>58</volume>(<issue>9</issue>):<fpage>1397</fpage>–<lpage>407</lpage>.doi: <pub-id pub-id-type="doi">10.1111/head.13396</pub-id><pub-id pub-id-type="pmid">30156267</pub-id>
</mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Wells</surname>  <given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Shea</surname>  <given-names>B</given-names></string-name>, <string-name name-style="western"><surname>O’Connell</surname>  <given-names>J</given-names></string-name></person-group>. <article-title>The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses</article-title>, <year>2014</year>. <comment>Accessed April 1, 2023</comment>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp" ext-link-type="uri">https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp</ext-link>.</mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Theeler</surname>  <given-names>BJ</given-names></string-name>, <string-name name-style="western"><surname>Flynn</surname>  <given-names>FG</given-names></string-name>, <string-name name-style="western"><surname>Erickson</surname>  <given-names>JC</given-names></string-name></person-group>. <article-title>Chronic daily headache in U.S. soldiers after concussion</article-title>. <source><italic toggle="yes">Headache</italic></source>. <year>2012</year>;<volume>52</volume>(<issue>5</issue>):<fpage>732</fpage>–<lpage>8</lpage>.doi: <pub-id pub-id-type="doi">10.1111/j.1526-4610.2012.02112.x</pub-id><pub-id pub-id-type="pmid">22404747</pub-id>
</mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Theeler</surname>  <given-names>BJ</given-names></string-name>, <string-name name-style="western"><surname>Erickson</surname>  <given-names>JC</given-names></string-name></person-group>. <article-title>Mild head trauma and chronic headaches in returning US soldiers</article-title>. <source><italic toggle="yes">Headache</italic></source>. <year>2009</year>;<volume>49</volume>(<issue>4</issue>):<fpage>529</fpage>–<lpage>34</lpage>.doi: <pub-id pub-id-type="doi">10.1111/j.1526-4610.2009.01345.x</pub-id><pub-id pub-id-type="pmid">19220499</pub-id>
</mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Finkel</surname>  <given-names>AG</given-names></string-name>, <string-name name-style="western"><surname>Yerry</surname>  <given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Scher</surname>  <given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Choi</surname>  <given-names>YS</given-names></string-name></person-group>. <article-title>Headaches in soldiers with mild traumatic brain injury: findings and phenomenologic descriptions</article-title>. <source><italic toggle="yes">Headache</italic></source>. <year>2012</year>;<volume>52</volume>(<issue>6</issue>):<fpage>957</fpage>–<lpage>65</lpage>.doi: <pub-id pub-id-type="doi">10.1111/j.1526-4610.2012.02167.x</pub-id><pub-id pub-id-type="pmid">22568576</pub-id>
</mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Jouzdani</surname>  <given-names>SR</given-names></string-name>, <string-name name-style="western"><surname>Ebrahimi</surname>  <given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Rezaee</surname>  <given-names>M</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Characteristics of posttraumatic headache following mild traumatic brain injury in military personnel in Iran</article-title>. <source><italic toggle="yes">Environ Health Prev Med</italic></source>. <year>2014</year>;<volume>19</volume>(<issue>6</issue>):<fpage>422</fpage>–<lpage>8</lpage>.doi: <pub-id pub-id-type="doi">10.1007/s12199-014-0409-3</pub-id><pub-id pub-id-type="pmid">25216772</pub-id>
<pub-id pub-id-type="pmcid">PMC4235850</pub-id></mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Finkel</surname>  <given-names>AG</given-names></string-name>, <string-name name-style="western"><surname>Yerry</surname>  <given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Klaric</surname>  <given-names>JS</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Headache in military service members with a history of mild traumatic brain injury: a cohort study of diagnosis and classification</article-title>. <source><italic toggle="yes">Cephalalgia</italic></source>. <year>2017</year>;<volume>37</volume>(<issue>6</issue>):<fpage>548</fpage>–<lpage>59</lpage>.doi: <pub-id pub-id-type="doi">10.1177/0333102416651285</pub-id><pub-id pub-id-type="pmid">27206963</pub-id>
</mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Metti</surname>  <given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Schwab</surname>  <given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Finkel</surname>  <given-names>A</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Posttraumatic vs nontraumatic headaches: a phenotypic analysis in a military population</article-title>. <source><italic toggle="yes">Neurology</italic></source>. <year>2020</year>;<volume>94</volume>(<issue>11</issue>):<fpage>e1137</fpage>–<lpage>46</lpage>.doi: <pub-id pub-id-type="doi">10.1212/WNL.0000000000008935</pub-id><pub-id pub-id-type="pmid">31924681</pub-id>
</mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Management of Concussion/mTBI Working Group</collab>
</person-group>. <article-title>VA/DoD clinical practice guideline for management of concussion/mild traumatic brain injury</article-title>. <source><italic toggle="yes">J Rehabil Res Dev</italic></source>. <year>2009</year>;<volume>46</volume>(<issue>6</issue>):<fpage>Cp1</fpage>–<lpage>68</lpage>.doi: <pub-id pub-id-type="doi">10.1682/JRRD.2008.03.0038</pub-id><pub-id pub-id-type="pmid">20108447</pub-id>
</mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="book">
<person-group person-group-type="author">
<collab>CDC</collab>
</person-group>. <article-title>Report to congress on mild traumatic brain injury in the United States: steps to prevent a serious public health problem</article-title>. <publisher-loc>Atlanta, GA</publisher-loc>; <year>2003</year>.</mixed-citation></ref><ref id="R36"><label>36.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Ashina</surname>  <given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Iljazi</surname>  <given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Amin</surname>  <given-names>FM</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Interrelations between migraine-like headache and persistent post-traumatic headache attributed to mild traumatic brain injury: a prospective diary study</article-title>. <source><italic toggle="yes">J Headache Pain</italic></source>. <year>2020</year>;<volume>21</volume>(<issue>1</issue>):<page-range>134</page-range>.doi: <pub-id pub-id-type="doi">10.1186/s10194-020-01202-6</pub-id><pub-id pub-id-type="pmcid">PMC7678268</pub-id><pub-id pub-id-type="pmid">33213358</pub-id></mixed-citation></ref><ref id="R37"><label>37.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Buture</surname>  <given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Ahmed</surname>  <given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Dikomitis</surname>  <given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Boland</surname>  <given-names>JW</given-names></string-name></person-group>. <article-title>Systematic literature review on the delays in the diagnosis and misdiagnosis of cluster headache</article-title>. <source><italic toggle="yes">Neurol Sci</italic></source>. <year>2019</year>;<volume>40</volume>(<issue>1</issue>):<fpage>25</fpage>–<lpage>39</lpage>.doi: <pub-id pub-id-type="doi">10.1007/s10072-018-3598-5</pub-id><pub-id pub-id-type="pmid">30306398</pub-id>
<pub-id pub-id-type="pmcid">PMC6329709</pub-id></mixed-citation></ref><ref id="R38"><label>38.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Wilk</surname>  <given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Thomas</surname>  <given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>McGurk</surname>  <given-names>DM</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Mild traumatic brain injury (concussion) during combat: lack of association of blast mechanism with persistent postconcussive symptoms</article-title>. <source><italic toggle="yes">J Head Trauma Rehabil</italic></source>. <year>2010</year>;<volume>25</volume>(<issue>1</issue>):<fpage>9</fpage>–<lpage>14</lpage>.doi: <pub-id pub-id-type="doi">10.1097/HTR.0b013e3181bd090f</pub-id><pub-id pub-id-type="pmid">20051900</pub-id>
</mixed-citation></ref><ref id="R39"><label>39.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>DoD</surname>
</string-name>
</person-group>. <source>Annual Report to the Executive Agent</source>. FY09. <year>2009</year>. Accessed April 1, 2023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://blastinjuryresearch.health.mil/assets/docs/ea_report/FY09_Report_to_the_Executive_Agent.pdf" ext-link-type="uri">https://blastinjuryresearch.health.mil/assets/docs/ea_report/FY09_Report_to_the_Executive_Agent.pdf</ext-link>.</mixed-citation></ref><ref id="R40"><label>40.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Bryden</surname>  <given-names>DW</given-names></string-name>, <string-name name-style="western"><surname>Tilghman</surname>  <given-names>JI</given-names></string-name>, <string-name name-style="western"><surname>Hinds</surname>  <given-names>SR</given-names>  <suffix>2nd</suffix></string-name></person-group>. <article-title>Blast-related traumatic brain injury: current concepts and research considerations</article-title>. <source><italic toggle="yes">J Exp Neurosci</italic></source>. <year>2019</year>;<volume>13</volume>:<page-range>1179069519872213</page-range>.doi: <pub-id pub-id-type="doi">10.1177/1179069519872213</pub-id><pub-id pub-id-type="pmcid">PMC6743194</pub-id><pub-id pub-id-type="pmid">31548796</pub-id></mixed-citation></ref><ref id="R41"><label>41.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Vetvik</surname>  <given-names>KG</given-names></string-name>, <string-name name-style="western"><surname>MacGregor</surname>  <given-names>EA</given-names></string-name></person-group>. <article-title>Sex differences in the epidemiology, clinical features, and pathophysiology of migraine</article-title>. <source><italic toggle="yes">Lancet Neurol</italic></source>. <year>2017</year>;<volume>16</volume>(<issue>1</issue>):<fpage>76</fpage>–<lpage>87</lpage>.doi: <pub-id pub-id-type="doi">10.1016/S1474-4422(16)30293-9</pub-id><pub-id pub-id-type="pmid">27836433</pub-id>
</mixed-citation></ref><ref id="R42"><label>42.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<collab>MOD</collab>
</person-group>. <article-title>UK armed forces biannual diversity statistics: April 2022. Gov.uk. 2022</article-title>. <comment>Accessed March 16, 2023</comment>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.gov.uk/government/statistics/uk-armed-forces-biannual-diversity-statistics-april-2022" ext-link-type="uri">https://www.gov.uk/government/statistics/uk-armed-forces-biannual-diversity-statistics-april-2022</ext-link>.</mixed-citation></ref><ref id="R43"><label>43.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<collab>DOD</collab>
</person-group>. <article-title>Chapter 2: active duty members military one source 2021</article-title>. <comment>Accessed March 16, 2023</comment>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://demographics.militaryonesource.mil/chapter-2-gender/" ext-link-type="uri">https://demographics.militaryonesource.mil/chapter-2-gender/</ext-link>.</mixed-citation></ref><ref id="R44"><label>44.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Dumkrieger</surname>  <given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Chong</surname>  <given-names>CD</given-names></string-name>, <string-name name-style="western"><surname>Ross</surname>  <given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Berisha</surname>  <given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Schwedt</surname>  <given-names>TJ</given-names></string-name></person-group>. <article-title>Static and dynamic functional connectivity differences between migraine and persistent post-traumatic headache: A resting-state magnetic resonance imaging study</article-title>. <source><italic toggle="yes">Cephalalgia</italic></source>. <year>2019</year>;<volume>39</volume>(<issue>11</issue>):<fpage>1366</fpage>–<lpage>81</lpage>.doi: <pub-id pub-id-type="doi">10.1177/0333102419847728</pub-id><pub-id pub-id-type="pmid">31042064</pub-id>
</mixed-citation></ref><ref id="R45"><label>45.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Ashina</surname>  <given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Iljazi</surname>  <given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Al-Khazali</surname>  <given-names>HM</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Hypersensitivity to calcitonin gene-related peptide in post-traumatic headache</article-title>. <source><italic toggle="yes">Ann Neurol</italic></source>. <year>2020</year>;<volume>88</volume>(<issue>6</issue>):<fpage>1220</fpage>–<lpage>8</lpage>.doi: <pub-id pub-id-type="doi">10.1002/ana.25915</pub-id><pub-id pub-id-type="pmid">32959458</pub-id>
</mixed-citation></ref><ref id="R46"><label>46.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Ashina</surname>  <given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Al-Khazali</surname>  <given-names>HM</given-names></string-name>, <string-name name-style="western"><surname>Iljazi</surname>  <given-names>A</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Low plasma levels of calcitonin gene-related peptide in persistent post-traumatic headache attributed to mild traumatic brain injury</article-title>. <source><italic toggle="yes">Cephalalgia</italic></source>. <year>2020</year>;<volume>40</volume>(<issue>12</issue>):<fpage>1276</fpage>–<lpage>82</lpage>.doi: <pub-id pub-id-type="doi">10.1177/0333102420941115</pub-id><pub-id pub-id-type="pmid">32689824</pub-id>
</mixed-citation></ref><ref id="R47"><label>47.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Alpuente</surname>  <given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Gallardo</surname>  <given-names>VJ</given-names></string-name>, <string-name name-style="western"><surname>Asskour</surname>  <given-names>L</given-names></string-name></person-group>, <etal>et al.</etal>  <article-title>Salivary CGRP as diagnostic and migraine attack phase monitor biomarker: CGRP (in)dependent attacks</article-title>. <source>medRxiv</source>. 2020:2020.11.18.20233841.</mixed-citation></ref><ref id="R48"><label>48.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Alpuente</surname>  <given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Gallardo</surname>  <given-names>VJ</given-names></string-name>, <string-name name-style="western"><surname>Asskour</surname>  <given-names>L</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Salivary CGRP and erenumab treatment response: towards precision medicine in migraine</article-title>. <source><italic toggle="yes">Ann Neurol</italic></source>. <year>2022</year>;<volume>92</volume>(<issue>5</issue>):<fpage>846</fpage>–<lpage>59</lpage>.doi: <pub-id pub-id-type="doi">10.1002/ana.26472</pub-id><pub-id pub-id-type="pmid">36054144</pub-id>
</mixed-citation></ref><ref id="R49"><label>49.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Ashina</surname>  <given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Bendtsen</surname>  <given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Jensen</surname>  <given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Schifter</surname>  <given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Olesen</surname>  <given-names>J</given-names></string-name></person-group>. <article-title>Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks</article-title>. <source><italic toggle="yes">Pain</italic></source>. <year>2000</year>;<volume>86</volume>(<issue>1-2</issue>):<fpage>133</fpage>–<lpage>8</lpage>.doi: <pub-id pub-id-type="doi">10.1016/S0304-3959(00)00232-3</pub-id><pub-id pub-id-type="pmid">10779670</pub-id>
</mixed-citation></ref><ref id="R50"><label>50.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Ashina</surname>  <given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Dodick</surname>  <given-names>DW</given-names></string-name></person-group>. <article-title>Post-traumatic headache: pharmacologic management and targeting CGRP signaling</article-title>. <source><italic toggle="yes">Curr Neurol Neurosci Rep</italic></source>. <year>2022</year>;<volume>22</volume>(<issue>2</issue>):<fpage>105</fpage>–<lpage>11</lpage>.doi: <pub-id pub-id-type="doi">10.1007/s11910-022-01175-w</pub-id><pub-id pub-id-type="pmid">35138589</pub-id>
</mixed-citation></ref><ref id="R51"><label>51.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Sevivas</surname>  <given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Fresco</surname>  <given-names>P</given-names></string-name></person-group>. <article-title>Treatment of resistant chronic migraine with anti-CGRP monoclonal antibodies: a systematic review</article-title>. <source><italic toggle="yes">Eur J Med Res</italic></source>. <year>2022</year>;<volume>27</volume>(<issue>1</issue>):<page-range>86</page-range>.doi: <pub-id pub-id-type="doi">10.1186/s40001-022-00716-w</pub-id><pub-id pub-id-type="pmcid">PMC9167529</pub-id><pub-id pub-id-type="pmid">35659086</pub-id></mixed-citation></ref><ref id="R52"><label>52.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Erickson</surname>  <given-names>JC</given-names></string-name>
</person-group>. <article-title>Treatment outcomes of chronic post-traumatic headaches after mild head trauma in US soldiers: an observational study</article-title>. <source><italic toggle="yes">Headache</italic></source>. <year>2011</year>;<volume>51</volume>(<issue>6</issue>):<fpage>932</fpage>–<lpage>44</lpage>.doi: <pub-id pub-id-type="doi">10.1111/j.1526-4610.2011.01909.x</pub-id><pub-id pub-id-type="pmid">21592097</pub-id>
</mixed-citation></ref><ref id="R53"><label>53.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Ashina</surname>  <given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Iljazi</surname>  <given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Al-Khazali</surname>  <given-names>HM</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Efficacy, tolerability, and safety of erenumab for the preventive treatment of persistent post-traumatic headache attributed to mild traumatic brain injury: an open-label study</article-title>. <source><italic toggle="yes">J Headache Pain</italic></source>. <year>2020</year>;<volume>21</volume>(<issue>1</issue>):<page-range>62</page-range>.doi: <pub-id pub-id-type="doi">10.1186/s10194-020-01136-z</pub-id><pub-id pub-id-type="pmcid">PMC7271543</pub-id><pub-id pub-id-type="pmid">32493206</pub-id></mixed-citation></ref><ref id="R54"><label>54.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Labastida-Ramírez</surname>  <given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Benemei</surname>  <given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Albanese</surname>  <given-names>M</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Persistent post-traumatic headache: a migrainous loop or not? The clinical evidence</article-title>. <source><italic toggle="yes">J Headache Pain</italic></source>. <year>2020</year>;<volume>21</volume>(<issue>1</issue>):<page-range>55</page-range>.doi: <pub-id pub-id-type="doi">10.1186/s10194-020-01122-5</pub-id><pub-id pub-id-type="pmcid">PMC7245945</pub-id><pub-id pub-id-type="pmid">32448142</pub-id></mixed-citation></ref><ref id="R55"><label>55.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Turner</surname>  <given-names>DP</given-names></string-name>, <string-name name-style="western"><surname>Smitherman</surname>  <given-names>TA</given-names></string-name>, <string-name name-style="western"><surname>Black</surname>  <given-names>AK</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Are migraine and tension-type headache diagnostic types or points on a severity continuum? An exploration of the latent taxometric structure of headache</article-title>. <source><italic toggle="yes">Pain</italic></source>. <year>2015</year>;<volume>156</volume>(<issue>7</issue>):<fpage>1200</fpage>–<lpage>7</lpage>.doi: <pub-id pub-id-type="doi">10.1097/j.pain.0000000000000157</pub-id><pub-id pub-id-type="pmid">25775357</pub-id>
<pub-id pub-id-type="pmcid">PMC4524296</pub-id></mixed-citation></ref></ref-list></back></article>